Pharmaceutical Drugs Market Global Report 2017
出 版 商：TBRC
出版日期：2017/07/17
頁 數：250頁
文件格式：PDF
價 格：
USD 6,000 (Single-User License)
USD 9,000 (Multi-User License)
USD 12,000 (Global-User License)
USD 6,000 (Hard copy)
USD 9,000 (Multi-User License)
USD 12,000 (Global-User License)
USD 6,000 (Hard copy)
The market segments in the pharmaceuticals drugs sector as of 2016 were Oncology, Anti-diabetics, Anti-rheumatics, Anti-virals, Vaccines, Bronchodilators, Sensory Organs, Anti-hypertensives, MS Therapies, Immunosuppressants, Anti-coagulants, Dermatologicals, Anti-hyperlipidaemics, Anti-fibrinolytics and Anti-bacterials.
Pharmaceuticals Drugs was the largest segment in the pharmaceuticals market with over 80% share of the market. Pharmaceuticals Drugs are chemical substances used to treat, cure, prevent or diagnose a disease. Biologics was the second largest segment in the pharmaceuticals market with around 20% share of the market. Biologics comprises products such as vaccines, blood and blood components, allergenic, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins extracted or semi synthesized from biological sources.
The Americas was the largest region in the pharmaceutical market in 2016, accounting for around 45% market share. Asia was the second largest region accounting for around 27% market share. Europe was the third largest region accounting for around 22% market share.
Rise of Biologics/Gene Therapy was observed to be one of the top trends in the pharmaceuticals industry as of 2016. Advances in genetics, molecular biology and gene delivery technologies have led to an increase in gene therapies to treat a number of diseases. Gene therapy treatment includes the isolation and transfer of stem cell populations, administration of effector cells and induction of pluripotent cells. Applications of gene therapy and biologics are primarily in cancer, cardiovascular and central nervous system diseases. Gene therapy is being widely used by healthcare service providers as it has the potential to cure hereditary diseases such as cystic fibrosis and also has the scope to treat heart diseases and cancer. For instance, cancer gene therapy is expected to be around $4.3 billion, thus indicating high demand for gene therapy
Pharmaceuticals Drugs was the largest segment in the pharmaceuticals market with over 80% share of the market. Pharmaceuticals Drugs are chemical substances used to treat, cure, prevent or diagnose a disease. Biologics was the second largest segment in the pharmaceuticals market with around 20% share of the market. Biologics comprises products such as vaccines, blood and blood components, allergenic, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins extracted or semi synthesized from biological sources.
The Americas was the largest region in the pharmaceutical market in 2016, accounting for around 45% market share. Asia was the second largest region accounting for around 27% market share. Europe was the third largest region accounting for around 22% market share.
Rise of Biologics/Gene Therapy was observed to be one of the top trends in the pharmaceuticals industry as of 2016. Advances in genetics, molecular biology and gene delivery technologies have led to an increase in gene therapies to treat a number of diseases. Gene therapy treatment includes the isolation and transfer of stem cell populations, administration of effector cells and induction of pluripotent cells. Applications of gene therapy and biologics are primarily in cancer, cardiovascular and central nervous system diseases. Gene therapy is being widely used by healthcare service providers as it has the potential to cure hereditary diseases such as cystic fibrosis and also has the scope to treat heart diseases and cancer. For instance, cancer gene therapy is expected to be around $4.3 billion, thus indicating high demand for gene therapy
1. Pharmaceutical Drugs Market Characteristics;
2. Pharmaceutical Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Pharmaceutical Drugs Market Customer Information;
5. Pharmaceutical Drugs Market Segmentation;
5.1. Global Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 5.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3. Global Pharmaceutical Drugs Market Trends And Strategies; 5.4. Global Pharmaceutical Drugs Market Compared With Similar Markets, 2016; 5.5. Global Pharmaceutical Drugs Market Compared With Similar Markets, 2012 – 2020, Historic and Forecast; 5.6. Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Region; 5.7. Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Country; 5.8. Cardiovascular Disorders; 5.8.1. Market Characteristics; 5.8.2. Global Cardiovascular Disorders Market, 2016, By Segment; 5.8.3. Market Trends And Strategies; 5.9. Dermatology; 5.9.1. Market Characteristics; 5.9.2. Global Dermatology Market, 2016, By Segment; 5.9.3. Market Trends And Strategies; 5.10. Gastrointestinal Diseases; 5.10.1. Market Characteristics; 5.10.2. Global Gastrointestinal Diseases Market, 2016, By Segment; 5.10.3. Market Trends And Strategies; 5.11. Genito-urinary Disorders; 5.11.1. Market Characteristics; 5.11.2. Global Genito-urinary Disorders Market, 2016, By Segment; 5.11.3. Market Trends And Strategies; 5.12. Hematology; 5.12.1. Market Characteristics; 5.12.2. Global Hematology Market, 2016, By Segment; 5.12.3. Market Trends And Strategies; 5.13. Infectious Diseases; 5.13.1. Market Characteristics; 5.13.2. Global Infectious Diseases Market, 2016, By Segment; 5.13.3. Market Trends And Strategies; 5.14. Metabolic Disorders; 5.14.1. Market Characteristics; 5.14.2. Global Metabolic Disorders Market, 2016, By Segment; 5.14.3. Market Trends And Strategies; 5.15. Musculoskeletal Disorders; 5.15.1. Market Characteristics; 5.15.2. Global Musculoskeletal Disorders Market, 2016, By Segment; 5.15.3. Market Trends And Strategies; 5.16. Central Nervous System; 5.16.1. Market Characteristics; 5.16.2. Global Central Nervous System Market, 2016, By Segment; 5.16.3. Market Trends And Strategies; 5.17. Oncology; 5.17.1. Market Characteristics; 5.17.2. Global Oncology Market, 2016, By Segment; 5.17.3. Market Trends And Strategies; 5.18. Ophthalmology; 5.18.1. Market Characteristics; 5.18.2. Global Ophthalmology Market, 2016, By Segment; 5.18.3. Market Trends And Strategies; 5.19. Respiratory Diseases; 5.19.1. Market Characteristics; 5.19.2. Global Respiratory Diseases Market, 2016, By Segment; 5.19.3. Market Trends And Strategies;
6. Pharmaceutical Drugs Market Regional And Country Analysis;
6.1. Global Pharmaceutical Drugs Market, 2016, By Region; 6.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Pharmaceutical Drugs Market, 2016, By Country; 6.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Market Segments, 2016, By Country;
7. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors;
7.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global;
8. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country;
9. Pharmaceutical Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Pharmaceutical Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Pharmaceutical Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Global Number Of General Practitioners 2016, By Country; 9.10. Global Pharmaceutical Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Pharmaceutical Drugs Market;
10.1.1. Asia-Pacific Pharmaceutical Drugs Market Overview; 10.1.2. Asia-Pacific Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.2. Asia-Pacific Pharmaceutical Drugs Market: Country Analysis; 10.3. China Pharmaceutical Drugs Market; 10.3.1. China Pharmaceutical Drugs Market Overview; 10.3.2. China Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.3.3. China Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.3.4. China Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.3.5. China Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 10.4. India Pharmaceutical Drugs Market; 10.4.1. India Pharmaceutical Drugs Market Overview; 10.4.2. India Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.4.3. India Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.4.4. India Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.4.5. India Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 10.5. Japan Pharmaceutical Drugs Market; 10.5.1. Japan Pharmaceutical Drugs Market Overview; 10.5.2. Japan Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 10.5.5. Japan Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 10.6. Australia Pharmaceutical Drugs Market; 10.6.1. Australia Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 10.6.4. Australia Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
11. Western Europe Pharmaceutical Drugs Market;
11.1.1. Western Europe Pharmaceutical Drugs Market Overview; 11.1.2. Western Europe Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.2. Western Europe Pharmaceutical Drugs Market: Country Analysis; 11.3. UK Pharmaceutical Drugs Market; 11.3.1. UK Pharmaceutical Drugs Market Overview; 11.3.2. UK Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.3.3. UK Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.3.5. UK Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.4. Germany Pharmaceutical Drugs Market; 11.4.1. Germany Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.4.4 Germany Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.5 France Pharmaceutical Drugs Market; 11.5.1 France Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.5.2 France Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.5.3 France Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.5.4 France Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.6. Italy Pharmaceutical Drugs Market; 11.6.1. Italy Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 11.6.4. Italy Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.7. Spain Pharmaceutical Drugs Market; 11.7.1. Spain Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.7.4. Spain Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
12. Eastern Europe Pharmaceutical Drugs Market;
12.1.1. Eastern Europe Pharmaceutical Drugs Market Overview; 12.1.2. Eastern Europe Pharmaceutical Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Pharmaceutical Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 12.2. Eastern Europe Pharmaceutical Drugs Market: Country Analysis; 12.3. Russia Pharmaceutical Drugs Market; 12.3. Russia Pharmaceutical Drugs Market; 12.3.1. Russia Pharmaceutical Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Pharmaceutical Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 12.3.4. Russia Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
13. North America Pharmaceutical Drugs Market;
13.1.1. North America Pharmaceutical Drugs Market Overview; 13.1.2. North America Pharmaceutical Drugs Historic Market, 2012 - 2016; 13.1.3. North America Pharmaceutical Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 13.2. North America Pharmaceutical Drugs Market: Country Analysis; 13.3. USA Pharmaceutical Drugs Market; 13.3.1. USA Pharmaceutical Drugs Historic Market, 2012 - 2016; 13.3.2. USA Pharmaceutical Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases13.3.4. USA Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
14. South America Pharmaceutical Drugs Market;
14.1.1. South America Pharmaceutical Drugs Market Overview; 14.1.2. South America Pharmaceutical Drugs Historic Market, 2012 - 2016; 14.1.3. South America Pharmaceutical Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 14.2. South America Pharmaceutical Drugs Market: Country Analysis; 14.3. Brazil Pharmaceutical Drugs Market; 14.3.1. Brazil Pharmaceutical Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Pharmaceutical Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 14.3.4. Brazil Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
15. Middle East Pharmaceutical Drugs Market;
15.1.1. Middle East Pharmaceutical Drugs Market Overview; 15.1.2. Middle East Pharmaceutical Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Pharmaceutical Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases;
16. Africa Pharmaceutical Drugs Market;
16.1.1. Africa Pharmaceutical Drugs Market Overview; 16.1.2. Africa Pharmaceutical Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Pharmaceutical Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases;
17. Pharmaceutical Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Johnson & Johnson; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Novartis Ag; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. F. Hoffmann-La Roche Ltd; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Pfizer Inc.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;
19. Market Background: Pharmaceuticals Market;
19.1.1. Pharmaceuticals Market Characteristics; 19.1.2. Pharmaceuticals Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceuticals Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceuticals Trends And Strategies; 19.2. Pharmaceuticals Market Regional And Country Analysis; 19.2.1. Global Pharmaceuticals Market, 2016, By Region; 19.2.2. Pharmaceuticals Market, 2016, By Country; 19.2.3. Pharmaceuticals Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.4. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Segment; 19.2.5. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceuticals Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceuticals Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceuticals Expenditure, Global; 19.4. Pharmaceuticals Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceuticals Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceuticals Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceuticals Market;
20. Healthcare Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
2. Pharmaceutical Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Pharmaceutical Drugs Market Customer Information;
5. Pharmaceutical Drugs Market Segmentation;
5.1. Global Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 5.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3. Global Pharmaceutical Drugs Market Trends And Strategies; 5.4. Global Pharmaceutical Drugs Market Compared With Similar Markets, 2016; 5.5. Global Pharmaceutical Drugs Market Compared With Similar Markets, 2012 – 2020, Historic and Forecast; 5.6. Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Region; 5.7. Pharmaceutical Drugs Market Compared With Similar Markets, 2016, By Country; 5.8. Cardiovascular Disorders; 5.8.1. Market Characteristics; 5.8.2. Global Cardiovascular Disorders Market, 2016, By Segment; 5.8.3. Market Trends And Strategies; 5.9. Dermatology; 5.9.1. Market Characteristics; 5.9.2. Global Dermatology Market, 2016, By Segment; 5.9.3. Market Trends And Strategies; 5.10. Gastrointestinal Diseases; 5.10.1. Market Characteristics; 5.10.2. Global Gastrointestinal Diseases Market, 2016, By Segment; 5.10.3. Market Trends And Strategies; 5.11. Genito-urinary Disorders; 5.11.1. Market Characteristics; 5.11.2. Global Genito-urinary Disorders Market, 2016, By Segment; 5.11.3. Market Trends And Strategies; 5.12. Hematology; 5.12.1. Market Characteristics; 5.12.2. Global Hematology Market, 2016, By Segment; 5.12.3. Market Trends And Strategies; 5.13. Infectious Diseases; 5.13.1. Market Characteristics; 5.13.2. Global Infectious Diseases Market, 2016, By Segment; 5.13.3. Market Trends And Strategies; 5.14. Metabolic Disorders; 5.14.1. Market Characteristics; 5.14.2. Global Metabolic Disorders Market, 2016, By Segment; 5.14.3. Market Trends And Strategies; 5.15. Musculoskeletal Disorders; 5.15.1. Market Characteristics; 5.15.2. Global Musculoskeletal Disorders Market, 2016, By Segment; 5.15.3. Market Trends And Strategies; 5.16. Central Nervous System; 5.16.1. Market Characteristics; 5.16.2. Global Central Nervous System Market, 2016, By Segment; 5.16.3. Market Trends And Strategies; 5.17. Oncology; 5.17.1. Market Characteristics; 5.17.2. Global Oncology Market, 2016, By Segment; 5.17.3. Market Trends And Strategies; 5.18. Ophthalmology; 5.18.1. Market Characteristics; 5.18.2. Global Ophthalmology Market, 2016, By Segment; 5.18.3. Market Trends And Strategies; 5.19. Respiratory Diseases; 5.19.1. Market Characteristics; 5.19.2. Global Respiratory Diseases Market, 2016, By Segment; 5.19.3. Market Trends And Strategies;
6. Pharmaceutical Drugs Market Regional And Country Analysis;
6.1. Global Pharmaceutical Drugs Market, 2016, By Region; 6.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Pharmaceutical Drugs Market, 2016, By Country; 6.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Market Segments, 2016, By Country;
7. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors;
7.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global;
8. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country;
9. Pharmaceutical Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Pharmaceutical Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Pharmaceutical Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Pharmaceutical Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Global Number Of General Practitioners 2016, By Country; 9.10. Global Pharmaceutical Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Pharmaceutical Drugs Market;
10.1.1. Asia-Pacific Pharmaceutical Drugs Market Overview; 10.1.2. Asia-Pacific Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.2. Asia-Pacific Pharmaceutical Drugs Market: Country Analysis; 10.3. China Pharmaceutical Drugs Market; 10.3.1. China Pharmaceutical Drugs Market Overview; 10.3.2. China Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.3.3. China Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.3.4. China Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.3.5. China Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 10.4. India Pharmaceutical Drugs Market; 10.4.1. India Pharmaceutical Drugs Market Overview; 10.4.2. India Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.4.3. India Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.4.4. India Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases10.4.5. India Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 10.5. Japan Pharmaceutical Drugs Market; 10.5.1. Japan Pharmaceutical Drugs Market Overview; 10.5.2. Japan Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 10.5.5. Japan Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 10.6. Australia Pharmaceutical Drugs Market; 10.6.1. Australia Pharmaceutical Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Pharmaceutical Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 10.6.4. Australia Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
11. Western Europe Pharmaceutical Drugs Market;
11.1.1. Western Europe Pharmaceutical Drugs Market Overview; 11.1.2. Western Europe Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.2. Western Europe Pharmaceutical Drugs Market: Country Analysis; 11.3. UK Pharmaceutical Drugs Market; 11.3.1. UK Pharmaceutical Drugs Market Overview; 11.3.2. UK Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.3.3. UK Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.3.5. UK Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.4. Germany Pharmaceutical Drugs Market; 11.4.1. Germany Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.4.4 Germany Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.5 France Pharmaceutical Drugs Market; 11.5.1 France Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.5.2 France Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.5.3 France Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.5.4 France Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.6. Italy Pharmaceutical Drugs Market; 11.6.1. Italy Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 11.6.4. Italy Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020; 11.7. Spain Pharmaceutical Drugs Market; 11.7.1. Spain Pharmaceutical Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Pharmaceutical Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases11.7.4. Spain Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
12. Eastern Europe Pharmaceutical Drugs Market;
12.1.1. Eastern Europe Pharmaceutical Drugs Market Overview; 12.1.2. Eastern Europe Pharmaceutical Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Pharmaceutical Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 12.2. Eastern Europe Pharmaceutical Drugs Market: Country Analysis; 12.3. Russia Pharmaceutical Drugs Market; 12.3. Russia Pharmaceutical Drugs Market; 12.3.1. Russia Pharmaceutical Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Pharmaceutical Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 12.3.4. Russia Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
13. North America Pharmaceutical Drugs Market;
13.1.1. North America Pharmaceutical Drugs Market Overview; 13.1.2. North America Pharmaceutical Drugs Historic Market, 2012 - 2016; 13.1.3. North America Pharmaceutical Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 13.2. North America Pharmaceutical Drugs Market: Country Analysis; 13.3. USA Pharmaceutical Drugs Market; 13.3.1. USA Pharmaceutical Drugs Historic Market, 2012 - 2016; 13.3.2. USA Pharmaceutical Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases13.3.4. USA Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
14. South America Pharmaceutical Drugs Market;
14.1.1. South America Pharmaceutical Drugs Market Overview; 14.1.2. South America Pharmaceutical Drugs Historic Market, 2012 - 2016; 14.1.3. South America Pharmaceutical Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 14.2. South America Pharmaceutical Drugs Market: Country Analysis; 14.3. Brazil Pharmaceutical Drugs Market; 14.3.1. Brazil Pharmaceutical Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Pharmaceutical Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases; 14.3.4. Brazil Pharmaceutical Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Pharmaceutical Drugs Expenditure, 2012 - 2020;
15. Middle East Pharmaceutical Drugs Market;
15.1.1. Middle East Pharmaceutical Drugs Market Overview; 15.1.2. Middle East Pharmaceutical Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Pharmaceutical Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases;
16. Africa Pharmaceutical Drugs Market;
16.1.1. Africa Pharmaceutical Drugs Market Overview; 16.1.2. Africa Pharmaceutical Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Pharmaceutical Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Pharmaceutical Drugs Market, 2016, By Segment; Cardiovascular Drugs; Dermatological Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Drugs For Infectious Diseases; Drugs For Metabolic Disorders; Drugs For Musculoskeletal Disorders; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Drugs For Respiratory Diseases;
17. Pharmaceutical Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Johnson & Johnson; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Novartis Ag; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. F. Hoffmann-La Roche Ltd; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Pfizer Inc.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;
19. Market Background: Pharmaceuticals Market;
19.1.1. Pharmaceuticals Market Characteristics; 19.1.2. Pharmaceuticals Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceuticals Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceuticals Trends And Strategies; 19.2. Pharmaceuticals Market Regional And Country Analysis; 19.2.1. Global Pharmaceuticals Market, 2016, By Region; 19.2.2. Pharmaceuticals Market, 2016, By Country; 19.2.3. Pharmaceuticals Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.4. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Segment; 19.2.5. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceuticals Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceuticals Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceuticals Expenditure, Global; 19.4. Pharmaceuticals Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceuticals Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceuticals Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceuticals Market;
20. Healthcare Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
